TNFSF11 and osteoporosis: Since osteocyte death and RANKL derived from osteocytes have been shown to be involved in bone loss under various pathological conditions, such as osteoporosis, arthritis and osteonecrosis, it will be necessary to examine the pathological significance of the intronic enhancer in future studies.